KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Depreciation and Depletion (2017 - 2025)

Historic Depreciation and Depletion for Fulgent Genetics (FLGT) over the last 9 years, with Q3 2025 value amounting to $3.9 million.

  • Fulgent Genetics' Depreciation and Depletion rose 263.16% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year decrease of 714.29%. This contributed to the annual value of $16.4 million for FY2024, which is 628.57% down from last year.
  • Per Fulgent Genetics' latest filing, its Depreciation and Depletion stood at $3.9 million for Q3 2025, which was up 263.16% from $3.9 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Depreciation and Depletion high stood at $7.6 million for Q3 2022, and its period low was $1.9 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $4.0 million (2024), whereas its average is $4.2 million.
  • In the last 5 years, Fulgent Genetics' Depreciation and Depletion surged by 31894.35% in 2021 and then plummeted by 4342.11% in 2023.
  • Over the past 5 years, Fulgent Genetics' Depreciation and Depletion (Quarter) stood at $2.6 million in 2021, then soared by 192.31% to $7.6 million in 2022, then plummeted by 42.11% to $4.4 million in 2023, then decreased by 9.09% to $4.0 million in 2024, then dropped by 2.5% to $3.9 million in 2025.
  • Its Depreciation and Depletion stands at $3.9 million for Q3 2025, versus $3.9 million for Q2 2025 and $3.8 million for Q1 2025.